Company’s prospective, multi-center 240-patient, pivotal randomized controlled trial (RCT) earns AUA "Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s)” designation at conference’s ...
SAN JOSE, Calif., April 28, 2026 (GLOBE NEWSWIRE)-- Prodeon Medical, a medical device company developing minimally invasive treatments for benign prostatic hyperplasia (BPH), today announces that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results